Our top pick for
Balchem Corporation is a specialty chemicals business based in the US. Balchem Corporation shares (BCPC) are listed on the NASDAQ and all prices are listed in US Dollars. Balchem Corporation employs 1,342 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$79.34 - $132.50|
|50-day moving average||$124.76|
|200-day moving average||$115.34|
|Wall St. target price||$140.50|
|Dividend yield||$0.58 (0.47%)|
|Earnings per share (TTM)||$2.60|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Balchem Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Balchem Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Balchem Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, Balchem Corporation shares trade at around 49x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Balchem Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 10.2643. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Balchem Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Balchem Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $164.2 million.
The EBITDA is a measure of a Balchem Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$703.6 million|
|Operating margin TTM||16.08%|
|Gross profit TTM||$223.9 million|
|Return on assets TTM||6.09%|
|Return on equity TTM||10.77%|
|Market capitalisation||$4.1 billion|
TTM: trailing 12 months
There are currently 484,174 Balchem Corporation shares held short by investors – that's known as Balchem Corporation's "short interest". This figure is 2.9% up from 470,632 last month.
There are a few different ways that this level of interest in shorting Balchem Corporation shares can be evaluated.
Balchem Corporation's "short interest ratio" (SIR) is the quantity of Balchem Corporation shares currently shorted divided by the average quantity of Balchem Corporation shares traded daily (recently around 127079.79002625). Balchem Corporation's SIR currently stands at 3.81. In other words for every 100,000 Balchem Corporation shares traded daily on the market, roughly 3810 shares are currently held short.
However Balchem Corporation's short interest can also be evaluated against the total number of Balchem Corporation shares, or, against the total number of tradable Balchem Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Balchem Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Balchem Corporation shares in existence, roughly 10 shares are currently held short) or 0.0204% of the tradable shares (for every 100,000 tradable Balchem Corporation shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Balchem Corporation.
Find out more about how you can short Balchem Corporation stock.
Dividend payout ratio: 17.47% of net profits
Recently Balchem Corporation has paid out, on average, around 17.47% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.47% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Balchem Corporation shareholders could enjoy a 0.47% return on their shares, in the form of dividend payments. In Balchem Corporation's case, that would currently equate to about $0.58 per share.
While Balchem Corporation's payout ratio might seem low, this can signify that Balchem Corporation is investing more in its future growth.
Balchem Corporation's most recent dividend payout was on 21 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 23 December 2020 (the "ex-dividend date").
Balchem Corporation's shares were split on a 3:2 basis on 20 January 2010. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Balchem Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Balchem Corporation shares which in turn could have impacted Balchem Corporation's share price.
Over the last 12 months, Balchem Corporation's shares have ranged in value from as little as $79.3411 up to $132.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Balchem Corporation's is 0.5929. This would suggest that Balchem Corporation's shares are less volatile than average (for this exchange).
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.